Vivos Inc (RDGL)

[HoneyBager]

Good
- rdgl is confident in what was requested for this meeting on the 20th and what they will be discussing
- rdgl is confident in moving forward with approval or already prepared if fda wants more test

Bad
- fda uncertainty on if more tests are needed
- do we have a list of patients ready to go and how many will be needed

Either way I see no near term failure. And steady progression towards fda approval. Once approved I think the patient numbers increase exponentially with human trials which is great since we can see results in as little as a few months.